{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"familial-apolipoprotein-c-ii-deficiency","columns":[{"gene":"","key":"population-333abca2cc4120cc91b5","label":"Apolipoprotein C-II deficiency","mondoId":"MONDO:0008810","onsetQualifier":null,"originColumnKey":"MONDO:0008810/OMIM:207750","originalViews":[{"key":"MONDO:0008810/OMIM:207750","label":"Apolipoprotein C-II deficiency","scopeLabel":"OMIM:207750","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["1b623337b437bc4c39c49f9e707b7d3279446a331d56a0fe66cb8e4ab45bfc8f","3545912fe6d54a5a299d9cecb6741ca3466f5b4e5e331d7e90735ec2c2c74850","56422844c5d06b49ed3eafbe1166eabe56d6f7a085eb26680d5da71d2d837ba5","5deb60211af468f01fe6870ae46983b03c7821f0118bd5726925e58623c95877","83aeec3d831f812a1f6f46cef16f6a638e77c5fdac2530b720c3d65d91276a27","93d6ac13d22d60ba3dbdf29e7ad42a84c1859f0f6db6eaefa3283d58d8c277b9","a584ef83504f780dff8acca384291f92b9bdaed9f2888fe93d1cc2c69dc01bbd","dbaab3098a29243865b58d833d5d6fea525c498841a4cbc7c344c61df5aeb6f9","eabce8a3827243caef87e4627990cc6e840177dae48a1bc19fec63667ddec43e"],"recordQualifiers":{},"scopeLabel":"OMIM:207750","sourceIds":["OMIM:207750"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-333abca2cc4120cc91b5"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0033983","HP:0001013","HP:0002240","HP:0003124","HP:0002155","HP:0012238","HP:0000660"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":9,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":9,"sourceGroups":{"published":9}},"features":[{"hpoId":"HP:0033983","label":"Decreased circulating apolipoprotein C-II concentration","primary":true},{"hpoId":"HP:0001013","label":"Eruptive xanthomas","primary":true},{"hpoId":"HP:0002240","label":"Hepatomegaly","primary":true},{"hpoId":"HP:0003124","label":"Hypercholesterolemia","primary":true},{"hpoId":"HP:0002155","label":"Hypertriglyceridemia","primary":true},{"hpoId":"HP:0012238","label":"Increased circulating chylomicron concentration","primary":true},{"hpoId":"HP:0000660","label":"Lipemia retinalis","primary":true},{"hpoId":"HP:0001733","label":"Pancreatitis","primary":false},{"hpoId":"HP:0001744","label":"Splenomegaly","primary":false}],"ledeHtml":"Familial apolipoprotein C-II deficiency is characterized by hepatomegaly, pancreatitis, splenomegaly, and skin eruptions. It is clinically and biochemically similar to lipoprotein lipase deficiency, or hyperlipoproteinemia type I, and is therefore referred to as hyperlipoproteinemia type IB. This condition is inherited in an autosomal recessive pattern and is caused by mutations in the APOC2 gene.","mondoId":"MONDO:0008810","node":{"canonicalSlug":"familial-apolipoprotein-c-ii-deficiency","comparisons":[{"documentSha256":"1565f9acc5df3ed456d6fc940d20c09c86529e1f35d14a0e23f44cf1b23a7d71","key":"legacy-familial-apolipoprotein-c-ii-deficiency","kind":"legacy","label":"familial apolipoprotein C-II deficiency","memberIds":["MONDO:0008810"],"mondoId":"MONDO:0008810","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/familial-apolipoprotein-c-ii-deficiency.1565f9acc5df3ed456d6fc940d20c09c86529e1f35d14a0e23f44cf1b23a7d71.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Familial apolipoprotein C-II deficiency","originalSourceId":"ORPHA:309020","paragraphs":["Familial apolipoprotein C-II deficiency is characterized by hepatomegaly, pancreatitis, splenomegaly, and skin eruptions. It is clinically and biochemically similar to lipoprotein lipase deficiency, or hyperlipoproteinemia type I, and is therefore referred to as hyperlipoproteinemia type IB. This condition is inherited in an autosomal recessive pattern and is caused by mutations in the APOC2 gene."],"rawAttribution":"ORPHA:309020","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-21T17:06:07Z","upstream":"OMIM:207750","url":"https://rarediseases.info.nih.gov/diseases/759"},"ownColumnKeys":["population-333abca2cc4120cc91b5"],"publication":"published","relationships":[{"kind":"parent","label":"familial hyperlipidemia","mondoId":"MONDO:0001336","slug":"familial-hyperlipidemia"},{"kind":"parent","label":"syndromic dyslipidemia","mondoId":"MONDO:0015905","slug":null},{"kind":"parent","label":"familial chylomicronemia syndrome","mondoId":"MONDO:0018637","slug":"familial-chylomicronemia"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"count","key":"1b623337b437bc4c39c49f9e707b7d3279446a331d56a0fe66cb8e4ab45bfc8f","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:207750","disease_name":"Apolipoprotein C-II deficiency","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0003124","is_excluded":false,"label":"Hypercholesterolemia","onset_id":null,"reference":"PMID:12783430","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"3545912fe6d54a5a299d9cecb6741ca3466f5b4e5e331d7e90735ec2c2c74850","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:207750","disease_name":"Apolipoprotein C-II deficiency","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0001744","is_excluded":false,"label":"Splenomegaly","onset_id":null,"reference":"PMID:3944267","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"56422844c5d06b49ed3eafbe1166eabe56d6f7a085eb26680d5da71d2d837ba5","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:207750","disease_name":"Apolipoprotein C-II deficiency","evidence":"PCS","frequency_raw":"10/10","hpo_id":"HP:0012238","is_excluded":false,"label":"Increased circulating chylomicron concentration","onset_id":null,"reference":"PMID:213719","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"5deb60211af468f01fe6870ae46983b03c7821f0118bd5726925e58623c95877","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:207750","disease_name":"Apolipoprotein C-II deficiency","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0000660","is_excluded":false,"label":"Lipemia retinalis","onset_id":null,"reference":"PMID:12783430","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"83aeec3d831f812a1f6f46cef16f6a638e77c5fdac2530b720c3d65d91276a27","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:207750","disease_name":"Apolipoprotein C-II deficiency","evidence":"PCS","frequency_raw":"4/6","hpo_id":"HP:0002240","is_excluded":false,"label":"Hepatomegaly","onset_id":null,"reference":"PMID:12783430;PMID:213719;PMID:3944267","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"93d6ac13d22d60ba3dbdf29e7ad42a84c1859f0f6db6eaefa3283d58d8c277b9","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:207750","disease_name":"Apolipoprotein C-II deficiency","evidence":"PCS","frequency_raw":"5/8","hpo_id":"HP:0001733","is_excluded":false,"label":"Pancreatitis","onset_id":null,"reference":"PMID:213719","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"a584ef83504f780dff8acca384291f92b9bdaed9f2888fe93d1cc2c69dc01bbd","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:207750","disease_name":"Apolipoprotein C-II deficiency","evidence":"PCS","frequency_raw":"12/12","hpo_id":"HP:0002155","is_excluded":false,"label":"Hypertriglyceridemia","onset_id":null,"reference":"PMID:12783430;PMID:213719","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"dbaab3098a29243865b58d833d5d6fea525c498841a4cbc7c344c61df5aeb6f9","raw":{"aspect":"P","body_system":"skin","disease_id":"OMIM:207750","disease_name":"Apolipoprotein C-II deficiency","evidence":"PCS","frequency_raw":"1/10","hpo_id":"HP:0001013","is_excluded":false,"label":"Eruptive xanthomas","onset_id":null,"reference":"PMID:213719;PMID:3944267","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"eabce8a3827243caef87e4627990cc6e840177dae48a1bc19fec63667ddec43e","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:207750","disease_name":"Apolipoprotein C-II deficiency","evidence":"PCS","frequency_raw":"11/11","hpo_id":"HP:0033983","is_excluded":false,"label":"Decreased circulating apolipoprotein C-II concentration","onset_id":null,"reference":"PMID:213719;PMID:6547689;PMID:3944267","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/759\" rel=\"noreferrer\">GARD</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>OMIM:207750</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Familial apolipoprotein C-II deficiency is characterized by hepatomegaly, pancreatitis, splenomegaly, and skin eruptions. It is clinically and biochemically similar to lipoprotein lipase deficiency, or hyperlipoproteinemia type I, and is therefore referred to as hyperlipoproteinemia type IB. This condition is inherited in an autosomal recessive pattern and is caused by mutations in the APOC2 gene.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/759\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"familial-apolipoprotein-c-ii-deficiency","sourceDocuments":[{"name":"GARD: Familial apolipoprotein C-II deficiency","reviewed":null,"source_release":"2026-10-21T17:06:07Z","url":"https://rarediseases.info.nih.gov/diseases/759"}],"sourceNote":"","synonyms":["familial apoC-II deficiency","familial apolipoprotein C-II deficiency","hyperlipoproteinemia, type IB"],"takeawayHtml":"","title":"familial apolipoprotein C-II deficiency"},"schemaVersion":1}
